Their case-control evaluation of 188 women diagnosed with breast cancer from 2000 to 2010 has shown that a gene mutation of the gene connexin-47 was identified in a greater number of women who developed secondary lymphedema. This evidence concerns the gene GJC2 and breast carcinoma.